Emerging Global Leader Award (K43 Independent Clinical Trial Required)

Emerging Global Leader Award (K43 Independent Clinical Trial Required)

This is a reissue of the Emerging Global Leader Program (K43) to align with the clinical trials policy.

Details

• Agency: National Institutes of Health
• Department: Department of Health and Human Services
• Opportunity #: PAR-24-295
• Instrument: grant

Eligibility

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations); Applications for the K43 award must be submitted by academic education or research institutions in LMICs (as defined by the World Bank (http://data.worldbank.org/about/country-classifications/country-and-lending-groups; low-income, lower-middle-income, and upper-middle-income countries are included). FIC's Country Eligibility Notice (NOT-TW-12-011 Notice of Change in Country Eligibility for Fogarty International Training Grants ) applies to this NOFO and states that for competing and re-competing research training grant applications (including the K43 mechanism), with the exception of Sub-Saharan African countries, FIC will no longer accept applications from, or applications that involve training of scientists from upper-middle-income countries that are also members of the G20 major economies (http://www.g20.org/en/members). For additional information see FIC's Country Eligibility